PTK2 and neoplasm: We also found that VS-4718 treatment that was initiated 5 days post-inoculation of 1 × 106 SCC FAK-WT cells, when these had already formed palpable tumors of ∼50 mm3, led to complete tumor regression (Figure 7J).